If symptoms don't improve within 30 minutes, seek medical attention
Desai AS et al (2025) Finerenone in patients with a recent worsening heart failure event: the FINEARTS-HF Trial, (in eng)
Moreover, patients with PAD and diabetes are at very high risk of adverse cardiovascular events, including myocardial infarction, stroke, and death. The primary analysis of STRIDE showed that semaglutide had a dramatic effect on PAD outcomes, including improved walking distance and quality-of-life parameters, as well as the composite outcome of mortality limb events and rescue therapy initiation
However, this increase in fat oxidation did not lead to measurable changes in body composition in the study
Metabolites were identified and quantified using liquid chromatographymass spectrometry (LC-MS)
Appetite-suppressing effects generally become more pronounced as patients reach maintenance doses (5 mg to 15 mg weekly, depending on individual response and tolerability)